oral anticoagulants ppt PPT Powerpoint Presentations and Slides - View and Download

Search:

Recent Developments In New Oral Anticoagulants Eric Watts Basildon Hospital Background - AF Warfarin is effective, 2/3 risk reduction for CVA Better than maximal ...
... to be approved as new oral anticoagulants in the near future The future for anticoagulants Factor Xa is an attractive target for the design of new oral anticoagulants ...
K dependent Factors Affected by Oral Anticoagulants Anticoagulant drugs to treat thromboembolism Drug Class Prototype Action Effect Anticoagulant Parenteral Heparin ...

K dependent Factors Affected by Oral Anticoagulants Thrombi Acc to location & composition Arterial Occur in areas of rapid flow (arteries) In response to an injured or ...
ORAL DIRECT THROMBIN INHIBITORS Girish C & M Jayanthi Dept of Pharmacology ... Mandatory lab monitoring Drug interactions Why new oral anticoagulants ?
... plaque to prevent rethrombosis Reopro cont. Used with aspirin and heparin and is contraindicated in clients who have recently received oral anticoagulants or IV dextran.
Oral Anticoagulants in the Pipeline. Tracy Sprunger, Pharm.D., BCPS. Assistant Professor, Pharmacy Practice. Butler College of Pharmacy and Health Sciences
PT prolonged PTT prolonged Functional assays of vitamin K factors show low level Acquired coagulation disorders Vitamin K Antagonists Oral anticoagulants ...
Common anticoagulants encountered in the surgical setting. Antiplatelet medications. Oral anticoagulants. Standard Heparin. Herbal preparations. New anticoagulants
... Lupus-anticoagulant Malignancy Oral contraceptives Post-op and trauma Myeloproliferative disorders Therapies Heparin Monitor with APTT LMWH no HIT Oral anticoagulants (e ...
K dependent Factors Affected by Oral Anticoagulants Coumarins act here Coumarins act here Vitamin K Coumarins are competitive inhibitors Oral anticoagulants – 4 ...
... Objective 1: identify general reasons anticoagulants are given * Objective 2: identify the ... Caution: antiplatelet or warfarin therapy * Warfarin (Coumarin) 1st oral ...
The risk of significant bleeding in patients on oral anticoagulants and with a stable INR in the therapeutic range 2-4 (i.e.
Functional Assays of Lupus Anticoagulants aPTT Some manufacturers offer aPTT ... patients with LA will have a normal PT unless they are receiving oral anticoagulants or ...
... stays ANTICOAGULANT THERAPY Focus on venous thromboembolism (VTE) Focus on parenteral therapy Not topics for discussion today: Thrombolytic therapy Oral anticoagulants ...
New Anticoagulants: Beyond Warfarin and Heparin Rachel LaCount Resident in Pathology ... II, VII, IX, X Vit K = cofactor Warfarin blocks the reduction of Vit K Oral ...
... 75 mg once daily), aspirin/ extended-release dipyridamole (25 mg/200 mg bid), or cilostazol (100 mg bid) over no antiplatelet therapy (Grade 1A), oral anticoagulants ...
... Drugs Methimazole and propyithiouracil (PTU) Side effects/adverse effects Liver and bone marrow toxicity Interactions Increased activity of oral anticoagulants Additive ...
... calculated by body weight Q daily or Q12Hrly SC administration No Laboratory monitoring necessary Exceptions - children, obesity, renal failure Oral Anticoagulants ...
... to aid treatment compliance and avoid the serious consequences of thrombosis and bleeding Requirements of new prophylactic agents Key features of new oral anticoagulants ...
... vitamin K injection at birth Coagulation tests: Prolongation of PT and APTT, normal TT Conventional model of coagulation Vitamin K antagonism Oral anticoagulants ...
Lupus Anticoagulants Antiphospholipid antibodies (APA) are directed against ... abortion or thrombotic events Monitor anticoagulant therapy Oral anticoagulants ...
... sites then lodge  in lung (capillary level)  inadequate O2 & CO2 exchange occur (ie. pulmonary embolism & cerebral embolism) Oral & parenteral anticoagulants ...
Objectives Review the mechanisms of action between oral and parenteral ... and applications: Development of clinical guidelines for management of oral anticoagulants ...
... This chapter addresses the many general management questions related to anticoagulants ... VKAs with INRs > 10.0 and with no evidence of bleeding, we suggest that oral ...

Recent searches

dysfunctional uterine bleeding

,

bio equivalence

,

watershed management for evs project

,

engine systems and components

,

physical and genetic maps

,

accounting principles 9th edition ppt powerpoint presentations and slides of chapter 17

,

eliciting activities

,

drillinginfo

,

thyroid swelling

,

intellectual disabilities

,

solublization techniques

,

paramedic care: principles & practice volume 5 chapter 7

,

ppt chapter 20 adolescence and the life cycle

,

expert authors in our free article directory class c for sale

,

carrer counselling in maths

,

carrer counselling in maths

,

am110

,

intermediate accounting kieso ifrs chapter 24 ppt

,

a review of the applications of agent technology in traffic and transportation systems

,

chemical equipment symbols

,

sociology macionis chapter two

,

orchid culture techniques

,

preparing for an fda inspection

,

introduction of us cogsa

,

introduction of aquaculture

,

brand mapping

,

toy safety directive

,

microbial fuel cells quorum sensing

,

cased hole

,

intercooler

,

product displays

,

a ppt on the features of shakespearean sonnets

,

hypercortisolism

,

chapter 15 in mis 12th edition by laudon

,

communicating supportively

,

pokemon

,

human resource management, robert mathis, chapter 4

,

history of the development of the law of universal gravitation ppt

,

forklift refresher training

,

endocarditis in cardiac surgery ppt

,

turbine used in power plant

,

safe driving

,

active directory i

,

heinz weihrich

,

advance power system protection powerpoint (ppt) presentations

,

gear indexing

,

electricity act 2003 ppt

,

agent enrollment process in life insurance in india

,

o£ ¾¾ …•

,

b20

Partners: pdf search engine, weather forecast